Under the terms of the Company’s Articles of Association, the Board of Directors may determine the rights, preferences, and terms of the Company’s authorized but unissued shares of preferred stock.

As of February 1, 2020, the Company is authorized to issue 8.0 million shares of $0.002 par value preferred stock and 992.0 million shares of $0.002 par value common stock. As of February 1, 2020, and February 2, 2019, no shares of preferred stock were outstanding.

In June 2019, the Company executed a funded research and development agreement with a business partner. In conjunction with the agreement, the Company issued a warrant to purchase 9.0 million of the Company's common shares, subject to certain vesting and exercise conditions.

For the years ended February 1, 2020 and February 2, 2019, the Company withheld approximately 4.0 million and 2.7 million shares, or $98.3 million and $54.9 million, of common stock, respectively, in settlement of employee tax withholding obligations due upon the vesting of restricted stock.

During fiscal 2020, the Company declared and paid cash dividends of $0.24 per common share, or $159.6 million, on the Company’s outstanding common stock. During fiscal 2019, the Company declared and paid cash dividends of $0.24 per common share, or $148.1 million, on the Company’s outstanding common stock.

On March 12, 2020, the Company announced that its board of directors declared a cash dividend of $0.06 per share payable on April 22, 2020 to shareholders of record as of April 3, 2020.

On November 17, 2016, the Company announced that its Board of Directors authorized a $1.0 billion share repurchase plan. The newly authorized stock repurchase program replaced in its entirety the prior $3.25 billion stock repurchase program. On October 16, 2018, the Company announced that its Board of Directors authorized a $700 million addition to the balance of its existing share repurchase plan. The Company intends to effect share repurchases in accordance with the conditions of Rule 10b-18 under the Exchange Act, but may also make repurchases in the open market outside of Rule 10b-18 or in privately negotiated transactions. The share repurchase program will be subject to market conditions and other factors, and does not obligate the Company to repurchase any dollar amount or number of its common shares and the repurchase program may be extended, modified, suspended or discontinued at any time.

The Company repurchased 14.5 million of its common shares for $364.3 million, 6.0 million of its common shares for $104.0 million and 31.5 million of its common shares for $526.1 million in cash during fiscal 2020, 2019 and 2018, respectively. The repurchased shares were retired immediately after the repurchases were completed. The Company records all repurchases, as well as investment purchases and sales, based on their trade date. As of February 1, 2020, a total of 306.9 million shares have been repurchased to date under the Company’s share repurchase program for a total $4.2 billion in cash and there was $589.7 million remaining available for future share repurchases.

Subsequent to the year ended February 1, 2020 through March 16, 2020, the Company purchased an additional 0.8 million of its common shares for $17.2 million at an average price per share of $21.14.


	Shares Repurchased	Weighted- Average Price per Share		Amount Repurchased


Cumulative balance at January 28, 2017	254,904	$	12.75	$	3,250,481
Repurchase of common stock under the stock repurchase program (1)	31,460	$	16.72	526,075
Cumulative balance at February 3, 2018	286,365	$	13.19	3,776,557
Repurchase of common stock under the stock repurchase program (2)	6,041	$	17.21	103,974
Cumulative balance at February 2, 2019	292,406	$	13.27	3,880,531
Repurchase of common stock under the stock repurchase program (3)	14,486	$	25.15	364,272
Cumulative balance at February 1, 2020	306,892	$	13.83	$	4,244,803